Inclusion Criteria:  Male and female participants ages at least 18 years. The participant with diagnosis of mild to moderate stable psoriasis vulgaris. BSA involvement <10%. Capable of giving written informed consent.  Exclusion Criteria:  Planned Ultraviolet (UV) light therapy or prolonged exposure to natural or artificial sources of UV radiation during the study period. Known allergies to the active ingredient or excipients of the drug. Pregnant females, lactating females. The patients who were considered unsuitable to participate in the study by the investigators.